Clinical trials: Pulmonary Hypertension, Primary
Pulmonary Arterial Hypertension
Home-based Pulmonary Rehabilitation With Remote Monitoring in Pulmonary Arterial Hypertension
The purpose of this study is to test new technology and health coaching aimed to help people with PAH become more physically active in their daily lives.
- Trial name
- NCT05521113
- Testing
- Home Rehabilitation Monitoring System, Health coaching calls
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Mayo Clinic
Pulmonary Arterial Hypertension
Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension
This is a prospective pilot study to assess the plasma levels of particular proteins involved in the transforming growth factor beta (TGF-β) pathway and its down stream regulators, CHIP, as well as micro RNA molecules in subjects…
- Trial name
- NCT04489251
- Testing
- Protein Elisa analysis, microRNA analysis, whole exome sequencing
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Medical College of Wisconsin
Pulmonary Arterial Hypertension
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
The purpose of the DelIVery for PAH clinical study is to evaluate the safety of the Medtronic Model 10642 Implantable Intravascular Catheter when used with the Medtronic SynchroMed® II Implantable Infusion System to deliver…
- Trial name
- DelIVery (NCT01321073)
- Testing
- Model 10642 Implantable Intravascular Catheter
- Where
- 8 sites in United States
- Volunteers
- 64 people
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Pulmonary Hypertension, Pulmonary Arterial Hypertension
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
Subcutaneous treprostinil (Remodulin) is effective therapy for pulmonary arterial hypertension, a life threatening disease of the lung blood vessels.
- Trial name
- NCT01260454
- Testing
- Qutenza (8% capsaicin)
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- University of Rochester
Pulmonary Arterial Hypertension
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
Researchers are looking for other ways to treat pulmonary arterial hypertension (PAH). Sotatercept is a study medicine that is designed to treat PAH.
- Trial name
- LIGHTRAY EXT (NCT06925750)
- Testing
- Sotatercept, Background PAH Therapy
- Where
- 73 sites in United States, Argentina and 17 more
- Volunteers
- 130 people
- Sponsor
- Merck Sharp & Dohme LLC